07/10/2018

Newsletters of Interest

A Few Articles You Won’t Want to Miss:

• Our office manual keeps you informed
• The appeals address for commercial Coventry plans has changed
• Don’t let your network status change — complete your FDR attestation today
• Help is available if you’re having issues with the new Medicare cards
• Important pharmacy updates

And Much More….JUNE Mid-America Region Qtly Issue Available HERE

A Few Articles You Won’t Want to Miss:

• BCN is updating its clinical editing system
• Blue Care Network updates professional fees July 1
• Helpful hints to expedite your Provider Secured Services application
• Starting Oct. 1, additional specialty medications require authorization for BCN Advantage members
• BCBSM and BCN drug lists updated, available online
• How to accurately code for immunosuppression and immunodeficiency

And Much More…JULY/AUGUST Bi-Monthly Issue Available HERE

Current Issue Available HERE

Current Issue Available HERE   (once on the site, choose NEWS on the left side)

A Few Articles You Won’t Want to Miss:

• Prepare Now for Portal Closure (Oct. 3, 2018)
• Access FAQs for Information about Required Compliance Training
• Online Tool Provides Faster Preauthorization Determinations
• Manage Medical Record Requests with Ease
• Peer-to-peer Review Process Changing for Humana Medicare Advantage (MA) Products

And Much More…Latest Issue Available HERE

 A Few Articles You Won’t Want to Miss:

• Front & Center
  • Link Self-Service Updates and Enhancements
  • Updates to Notification/Prior Authorization Requirements for Specialty Medications for UnitedHealthcare Commercial and Community Plan Members
  • Process Change: Colony-Stimulating Factors

• UnitedHealthcare Commercial
  • UnitedHealthcare Genetic and Molecular Testing Prior Authorization/Notification Updates

•  UnitedHealthcare Medicare Advantage
  • Reimbursement for 340B Drug Pricing Program

And Much More…JULY Monthly Issue Available HERE

Oncology Related Articles You Won’t Want to Miss:

Medical Policy Updates

Revised:

• Apheresis – Effective Aug. 1, 2018

Medical Benefit Drug Policy Updates

New:

• Self-Administered Medications – Effective Jul. 1, 2018

Updated:

• Clotting Factors and Coagulant Blood Products – Effective Jul. 1, 2018
• Luxturna™ (Voretigene Neparvovec-Rzyl) – Effective Jul. 1, 2018
• Off-Label/Unproven Specialty Drug Treatment – Effective Jul. 1, 2018
• Oncology Medication Clinical Coverage – Effective Jul. 1, 2018

JULY Monthly Issue Available HERE